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ABSTRACT
PURPOSE: To evaluate morphological and functional aspects of the ovarian graft in transplanted rats treated with NAC. 
METHODS: Female Wistar rats, virgin, 3 to 4 months old, weighing 200-250 grams were used in experiments. The rats have been 
kept in proper sanitary conditions, receiving food and water ad libitum. Five groups (n=10, each) were constituted: 4 groups treated 
subcutaneously with NAC, at doses of 150, 300, 600 and 1200 mg/kg (NAC150, NAC300, NAC600 and NAC1200, respectively), 
one hour of before the ovarian transplantation and control group (GTx) – treated with physiological solution and submitted to 
ovarian transplantation. The rats were anesthetized and submitted to autologous left ovarian transplantation, without anastomosis in 
retroperitoneum, and contralateral oophorectomy. During follow-up of 4 or 15 days, the estrous cycle was evaluated by vaginal smears to 
determine cycle regularity. At the end of 4th or 15th days, rats were re-anesthetized and blood and graft were obtained to estradiol analysis 
and morphological assessment. Data were analysed by One Way Analysis of Variance (ANOVA) or ANOVA on ranks complemented 
by Student-Newman-Keuls test. 
RESULTS: At 4th day, viable follicles in the graft did not altered by NAC treatments. The NAC300 and NAC600 groups showed 
increasing in follicle atresia (p=0.012) compared to GTx and NAC1200 group. At 15th day, 50% of GTx, NAC150, and NAC300 
rats showed regular oestrous cycle; 83% of NAC600 and 100% of NAC1200 rats returned to regular cycle. NAC1200 group showed 
increasing in primordial follicle compared to GTx, NAC150 or NAC300 (p=0.011).  NAC did not interfere in estradiol levels after 4 or 
15 days of transplantation. 
CONCLUSION: In autologous ovarian transplantation, high dose of NAC promotes graft viability with recovery of estrous cycle. 
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INTRODUCTION
Life expectation of adult women, who survived 
adolescence or infancy cancer treatment has increased, thanks 
to early diagnostic and treatment in oncologic centers1,2. Early 
menopause induced by cancer treatment is often followed by 
osteoporosis, early cardiovascular diseases and infertility, besides 
a prolonged hormonal reposition treatment requirement (TRH)1. 
There are several alternatives aiming to reduce the 
adverse effects of chemotherapy and radiotherapy on ovaries, such 
as the transposition (temporary removal) of ovaries, also known 
as oophorectomy, the use of antagonistic drugs to Gonadotropin 
Releasing Hormones (GnRH) together with chemotherapy and 
new apoptosis antagonistic drugs3.  For those patients, who 
need immediate oncologic treatment, a promising option is the 
oophorectomy, the cryopreservation of ovaries and its posterior 
re-implantation, after the end of treatment1. For the preservation 
of treated women fertility, several techniques may be used: some 
already widely used, such as cryopreservation of embryos, mature 
or premature follicles, others are still experimental, such as the 
transplantation of ovarian tissue3,4.
Ovarian transplantation has been studied in several 
experiments, both on animals and humans, and has been described 
as a promising alternative for those patients, who will be submitted 
to oncologic treatment5,6.  Even thought, until now, it has been 
described a short survival time of the transplanted ovarian, with 
loss of more than 50% of the ovarian follicles after transplantation5. 
Several factors are involved in this problem, but ischemia seems to 
play an important role in this process.1,5
Some studies have been performed, in search for 
strategies for the attenuation of the ischemia and reperfusion lesion 
(I/R): angiogenic factors, which stimulate new vessels formation, 
antioxidating substances, such as E vitamin, GnRH analogous and 
ischemic preconditioning7-10.
Some previous works have shown the positive effect 
of N-Acetylcysteine (NAC) at 150 mg/kg dose on various 
organs. NAC is a low molecular weight thiol, it is derived from 
cysteine and acts removing  reacting species of oxygen, besides 
improving the action of nitric oxide, acting on the regulation of 
microcirculation11-13. Usta et al.14 showed NAC improved tissue 
recovering in ovaries, which had been submitted to torsion and 
distortion. Some other studies use NAC in polycystic ovarian 
syndrome patients, resulting in improved sensibility to insuline15,16. 
Considering the positive effects of NAC in clinical or 
experimental studies, this work aims to evaluate the post transplant 
effect of NAC on ovarian graft in rats treated with N-Acetylcysteine.
METHODS
This project was approved by the board of the Research 
Ethics Committee, UNIFESP, under protocol 0907/2010. 
Procedures have been performed at the laboratory of experimental 
microsurgery of UNIFESP.
Female Wistar rats, virgins, age 3 to 4 months, weight 200 
to 250 grams have been used. All animals came from the Center 
for Experimental Models Developing for Biology and Medicine, 
UNIFESP.  Animals were kept in proper sanitary conditions, 
having their environmental temperature and humidity checked, 
water and food always available along all experiment.
Daily, vaginal smears were performed during 8 days before 
of transplantation procedures to evaluate the estral cycle.  Females 
with regular cycle were selected, and ovarian transplantations were 
performed during diestrum. After transplantation, vaginal smears 
were performed daily and euthanasia was performed during estrum 
or proestrum stages. During follow-up of four or 15 days, vaginal 
smears were performed to determine cycle regularity return. 
One hour before ovarian transplantation, animals were 
randomly allocated into five groups, with 10 animals each, according 
to the treatment.  Four groups were treated subcutaneously - 
along the linea alba - with NAC, at doses of 150mg/kg, 300mg/
kg, 600mg/kg or 1200mg/kg - NAC150, NAC300, NAC600 and 
NAC1200 groups, respectively. One group was treated with 0.9% 
Sodium chloride solution and was considered control, named GTx. 
The autologous left ovarian transplantation was 
performed in anesthetized rat (Xilazine, 15 mg/kg and Ketamine, 
60 mg/kg). The anaesthesia was applied on the lateral side of the 
left hind leg, intramuscularly.
After medial laparotomy, the left ovarian was carefully 
removed, through a ligation of the pedicle, and on the junction of 
the left horn, using 6-0 size nylon. The left ovarian was washed 
using 0.9% Sodium chloride solution and uterine tubes and 
periovarian fat were removed. To ovarian transplantation, the left 
ovarian was fixed in retroperitoneal position, close to the large 
vessels and, without vascular anastomosis. The right ovarian was 
removed and anatomical-pathological evaluation was conducted 
to exclude previous existing disorders.
At the end of 4th or 15th days, rats were re-anesthetized 
and blood and graft were obtained to estradiol analysis and 
morphological assessment, respectively. 
The ovarian graft was fixed in 10% formalin and 
embedded to paraffin to histological procedures. Five micra slides 
were stained with haematoxylin-eosin and assessed by blinded 
investigator. 
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For the evaluation of follicular development, ovarian 
follicles were counted and classified in developing follicles, 
independently of their stages and atretic follicles, which were 
subdivided according to the degree of maturity into immature 
follicles (including primordial, preantral follicles) and antral 
follicles (with only one bulky antrum) besides the corpora lutea17. 
Measurements were obtained with the image analysis program 
AxionVision REL 4.6, Karl Zeiss. Counting was always performed 
in 4 fields per animal at 10x magnification.
Data are presented as mean±SED or median (interquartile 
range). The comparison among groups in the same time was 
analyzed by One Way Analysis of Variance (ANOVA) or ANOVA 
on ranks, when appropriated, complemented by Student-Newman-
Keuls test. Comparison between studied times was analyzed by 
Mann-Whitney test. Differences were considered for p<0.05.
RESULTS
After 4 or 14-16 days of follow-up, serological levels 
of estradiol were similar among groups (p=0.051 and p=0.51, 
respectively). 
At 4th day after transplantation, ovarian graft morphology 
indicated that NAC treatment promoted high numbers of atretic 
follicles in NAC300 and NAC600 groups (Figure 1). Primordial 
follicle, preantral follicle, antral follicle and functioning and 
degenerated corpora lutea were similar among groups. 
At 14th day after transplantation, ovarian graft 
morphology indicated that NAC treatment promoted high numbers 
of primordial follicles in NAC600 and NAC1200 groups (Figure 
2). Preantral follicle, antral follicle, atretic follicle, functioning 
and degenerated corpora lutea were similar among groups.
FIGURE 1 – Number of atretic follicle on 4th-day of autologous ovarian 
transplantation in rats. Rats previously treated with NAC at dosis of 
300 and 600 mg/kg (NAC300 and NAC600, respectively) augmented 
the number of atretic follicle in the graft. One way analysis of variance 
complemented by Student-Newman-Keuls test; *, p<0.05 vs control.
FIGURE 2 – Number of primordial follicle on 14th-day of autologous ovarian 
transplantation in rats. Rats previously treated with NAC at dosis of 600 
and 1200mg/kg (NAC600 and NAC1200, respectively) showed elevation 
in number of primordial follicle in graft. One way analysis of variance 
complemented by Student-Newman-Keuls test; *, p<0.05 vs control.
Groups
GTx NAC150 NAC300 NAC600 NAC1200
Primordial 
Follicles
4th 
day
2.2 ± 
0.66
1.00 ± 
0.32
2.80 ± 
0.37
1.00 ± 
0.55
1.80 ± 
0.58
14th 
day
2.20 ± 
0.49
1.33 ± 
0.56
1.77 ± 
0.63 
3.00 ± 
0.52*
4.16 ± 
0.97*#
Preantral 
Follicles
4th 
day
5.20 ± 
1.20
4.40 ± 
1.17
5.00± 
1.00
3.60 ± 
0.81
5.00 ± 
1.26
14th 
day
7.40 ± 
1.29
6.67 + 
0.99
7.20 ± 
2.89
6.17 ± 
1.68
8.20 ± 
1.43
Antral 
Follicles
4th 
day
0.40 ± 
0.24
0.40 ± 
0.24
0.60 ± 
0.24
0.60 ± 
0.26
0.40 ± 
0.24
14th 
day
1.42 ± 
0.51*
1.33 ± 
0.67
3.40 ± 
1.44
1.17 ± 
0.50
2.00 ± 
0.42*
Atretic 
Follicles
4th 
day
5.00 ± 
0.84
8.00 ± 
1.30
9.20 ± 
0.37#
9.80 ± 
1.80#
5.20 ± 
0.37
14th 
day
9.60 ± 
1.17*
8.67 ± 
1.84
6.80 ± 
1.36
6.50 ± 
0.85
4.00 ± 
0.55
Functioning 
Corpora 
Lutea
4th 
day
1.20 ± 
0.58
0.20 ± 
0.20
1.20 ± 
0.37
1.20 ± 
0.37
2.40 ± 
0.68
14th 
day
1.40 ± 
0.60
1.70 ± 
0.71*
2.20 + 
0.49
2.00 + 
0.45
3.00 + 
0.71
Degenerated 
Corpora 
Lutea
4th 
day
1.40 + 
0.40
1.40 + 
0.24
1.60 + 
0.40
1.80 ± 
0.58
2.00 + 
0.32
14th 
day
0.60 ± 
0.40
0.50 ± 
0.22*
0.20 ± 
0.20*
0.50 ± 
0.22*
0.40 ± 
0.24*
TABLE 1 – Follicles and Corpora Lutea after ovarian 
transplantation in groups treated with NAC in different doses. 
Mean±EPM; test-t between 4th and 14th days of follow-up *, p<0.05 vs 4th day; One 
way analysis of variance complemented by post-hoc test among groups, compared 
to control (GTx); #, p<0.05 vs GTx.
N-acetylcysteine improves morphologic and functional aspects of ovarian grafts in rats
Acta Cirúrgica Brasileira - Vol. 29 (supl. 3) 2014 - 25
The comparison between two intervals showed that high 
number of atretic follicle and antral follicle in GTx group in 14th 
day. NAC promoted a better preservation of viable follicles on 
latest time (14th day after surgery), showing significant results on 
those groups NAC300 and NAC600 (Table 1; Figure 3).
of the transplants, NAC treatment promoted a better preservation 
of the corpus luteum, reducing the degenerative process at the later 
analysis stage, on day 14. 
DISCUSSION
Experimental ovarian transplantation has been performed 
for some years: autologous, heterologous, with or without vascular 
pedicle, both in humans and laboratory animals. This operation has 
been performed in different sites of implantation, and the implants 
have been functional, both functionally and morphologically1,3,18.
At transplantation, half of the primordial follicles are 
lost, persisting until the stage of neoangiogenesis5. Many studies 
have tried to preserve the ovarian tissue from I/R lesion, using 
substances such as E vitamin, ascorbic acid, and GnRH analogous, 
or physical strategies including the ischemic preconditioning2,8-10.
Some work have already used NAC at different doses on 
several organs, such as kidney, liver, lungs, fasciocutaneous flap, 
intestine and ovarian, showing good results on I/R lesions12-14, 18-22.
So in order to mitigate the damage and I/R as the first 
study in ovarian transplantation, it was decided to give NAC 
subcutaneously, in order to have a better control over the given 
volumes and at different doses to determine the relation between 
the doses and the effect on the ovarian tissue.
There are further applications of NAC, besides its 
mucolytic activity, in the prevention of obstructive chronic lung 
disease, in the prevention of kidney complications during contrast 
procedures, in the reduction of viral flu and pulmonary fibrosis. 
Furthermore, NAC gave good results on fertility of patients with 
clomifen-resisting polycystic ovarian23. Recent studies have 
also suggested the use of NAC as chemiopreservative against 
cancer, auxiliary in the eradication of Helicobacter pylori, in the 
hearing loss caused by gentamycin in kidney dialysis patients, 
HIV infection, cardiac diseases, smoke and epileptic22. NAC used 
for long time (5-6 weeks) improved the sensibility to insulin, 
testosterone levels and lipidic profile in women affected by 
polycystic ovarian syndrome24.
A study realized on polycystic ovarian syndrome 
patients, which compared the effect of metformin to those of the 
association metformin + NAC for short times (5 days), showed 
NAC is effective in inducing ovulation, even if the number of 
mature follicles was not significant, as it was confirmed in our 
experience23, 25.
Oktay et al.26 observed the levels of estradiol in the 
xenotransplantation and found signals of a estrogenic effect in the 
genitalia, even if there was a lower number or absence of growth 
FIGURE 3 - Photomicrographs of ovarian grafts of the groups at 14 days 
: GTx (A), NAC150 (B), NAC300 (C), NAC600(D), NAC1200 (E). HE 
– 10 X.  F=Follicle CL=Corpus luteum 
Comparing the response of the animals at 4 and 14 days 
after surgery, the animals, which had been treated with NAC1200 
showed a better tissue preservation on later stage, with a significant 
higher number of premature follicles (p=0.018). In all treatment 
groups at day 14 after transplantation there was an increase in the 
number of functional corpora lutea, but this was significant just in 
the group treated with NAC150 (p=0.02). NAC 600 group showed 
a tendency instead (p=0.074). For what concerns to the degradation 
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of antral follicles. This observation confirms, genital organs 
of rodents are sensitive to low levels of sexual steroids2,26, data 
corroborates our results, as we detected low levels of estrogen 
in all transplanted groups, despite the histology showed graft 
functionality in the later phase. Callejo et al.27, analyzing the 
longevity of the grafts and estradiol levels, suggest, estradiol and 
FSH are reliable markers of the transplant functionality. The same 
authors, analyzing intraperitoneal and subcutaneous implantation 
of ovarian transplantations, found high estradiol levels and low 
FSH levels in the intraperitoneal transplantation of ovarians 
after 30 days27. Li et al.28 also describe an elevation of estradiol 
levels studying follicular growth and oocyte development after 
transplantation in muscle of spayed male mice.
D’Acampora et al.17 analysed the transplantation in 
female rats and perceived, on the 7th day the recovery of the 
follicular production, which persisted until the 14th day, with the 
presence of follicles in 75% of the ovaries. Israely et al.4 implanted 
grafted ovarian transplants in granulation tissues and showed 
better vascularization and an higher number of viable follicles, 
which may serve as a model to reduce the ischemic period and 
to extended the functionality of the transplant. In this same study 
NAC was important on the latest stage, protecting the follicles 
from being atretic, with an anti-apoptosis effect.
Damous et al.7 showed a tendency to the increase of 
the follicles number at 48 hours using PCI-R. It is important to 
stress the direct correlation existing between follicle size and 
its susceptibility to damages caused by ischemia: antral follicle 
has an higher tendency to degeneration than primordial follicle. 
According to Damous et al.7, PCI-R showed positive effects at 
the 5th day after surgery, with the presence of ovarian follicles at 
different development stages and corpus luteum, even if an intense 
inflammation infiltrate was present. D’Acampora et al.17 showed 
similar findings.
Fabbri et al.18 studied ovarian tissue from a woman, who 
suffered breast cancer at the age of 26: after freezing, defrosting and 
32 weeks growth, the authors could observe the synergy between 
NAC and FSH, with improvement on growth and preservation of 
the pre-antral follicle. On follicular growth, after some days of 
development, the follicle shows some signals of atresy.  In vitro 
studies have produced the complete development from primordial 
follicle to ovulatory mature follicle just in mice. In humans, the 
same studies have only produced the maturation from pre-antral 
to antral stage and from primordial to primary and secondary 
follicles25. The return to gonad functionality on long term ovarian 
transplantation depends on the survival and growth of the follicles, 
which itself depends, from the capacity to ovulate29.
CONCLUSION
In autologous ovarian transplantation, high dose of NAC 
promotes graft viability with recovery of estrous cycle.
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